Anti-KRAS-G12D T cell receptors
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsEric Tran, Yong-Chen Lu, Anna Pasetto, Paul F. Robbins, Steven A. Rosenberg, Zhili Zheng
Life of this patent
Estimating the term…
Abstract
Disclosed is an isolated or purified T cell receptor (TCR) having antigenic specificity for mutated Kirsten rat sarcoma viral oncogene homolog (KRAS) presented in the context of an HLA-Cw*0802 molecule. Related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions are also provided. Also disclosed are methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal.
Claims36
An isolated or purified TCR comprising the amino acid sequences of:
- (a) SEQ ID NOs:
- 9-14;
- (b) SEQ ID NOs:
- 17-22;
- (c) SEQ ID NOs:
- 25-27;
- (d) SEQ ID NOs:
- 28-30;
- (e) SEQ ID NOs:
- 33-35;
- or
- (f) SEQ ID NOs:
- 36-38.
An isolated or purified protein comprising:
- (a) a first polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 9-11 and a second polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 12-14;
- (b) a first polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 17-19 and a second polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 20-22;
- (c) a first polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 9-11 and a second polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 20-22;
- (d) a first polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 25-27 and a second polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 28-30;
- or
- (e) a first polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 33-35 and a second polypeptide chain comprising the amino acid sequences of SEQ ID NOs:
- 36-38.
An isolated or purified polypeptide comprising the amino acid sequences of:
- (a) SEQ ID NOs:
- 9-14;
- (b) SEQ ID NOs:
- 17-22;
- (c) SEQ ID NOs:
- 25-27;
- (d) SEQ ID NOs:
- 28-30;
- (e) SEQ ID NOs:
- 33-35;
- or
- (f) SEQ ID NOs:
- 36-38.
Dependencies are inferred from the claim text.